From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19
3 years, 2 months ago

From Merck’s Molnupiravir to Glenmark’s nasal spray, over 20 new drugs in pipeline for COVID-19

Firstpost  

While the market for these drugs may not be huge at present due to a drop in COVID-19 cases and extended timelines, experts believe that these drugs will help control future waves and protect people with weak immunity Merck’s Molnupiravir, Zydus’ antibody cocktail and Glenmark’s nasal spray are among more than 20 new drugs in different stages of drug trials or approvals in India to treat COVID-19. One of the biggest risks in clinical trials on COVID-19 therapies is that once cases come down, many companies may not see a big market for further research and trials. List of drugs in the pipeline US pharma giant Merck and Ridgeback Biotherapeutics’ oral antiviral treatment molnupiravir, which has shown to reduce the risk of hospitalisation or death by around 50 percent, — has been conducting trials in India through its partner companies Cipla, Dr Reddy’s Laboratories, Sun Pharmaceutical Industries and Torrent Pharmaceuticals. India’s apex scientific research body, CSIR, has been conducting Phase III trials of Umifenovir, a drug mainly used for treatment of influenza in China and Russia.

India Research Drugs Trials Clinical Trials Covid Infection Drug Vaccine Experts Merck Glenmark Lahariya Molnupiravir  cases  drugs  spray  vaccines  experts  molnupiravir  covid19  drug  20  research  nasal  trials  glenmarks  mercks  infection  vaccine  pipeline

History of this topic

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
3 months, 3 weeks ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

After four years of pandemic, Covid virus to be seasonal flu in young population
9 months, 1 week ago

After four years of pandemic, Covid virus to be seasonal flu in young population

Hindustan Times  

Monday marks four years since the World Health Organisation declared Covid-19 a pandemic. With the availability of Covid-19 vaccines and medicines, the virus will become much like a regular flu or seasonal infection in the younger population. Health experts claimed that the SARS-CoV-2 infection will now be much like a regular flu, respiratory syncytial virus and other seasonal infections in …

Does frequently updating COVID-19 vaccines have any benefits? | Explained
10 months, 1 week ago

Does frequently updating COVID-19 vaccines have any benefits? | Explained

The Hindu  

Researchers update the composition of influenza vaccines every six months to match the strains of the virus that are circulating in the wild, so that the shots may provide protective immunity against the flu. The VE of COVID-19 vaccines varies according to the disease’s progression as well as the circulating strains. Thus, researchers worldwide rushed to revise COVID-19 vaccines that …

Do special nasal sprays work to protect you from COVID?
1 year ago

Do special nasal sprays work to protect you from COVID?

Slate  

We’re in the fourth holiday season in which COVID is a reality that we have to deal with—and while most protective measures have disappeared from public view, some people are trying new approaches to avoid getting sick. One of these tools I’m seeing more and more on social media is nasal sprays of all types, with some influencers suggesting the …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 5 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

India saved 3.4mn people through Covid-19 vaccination drive: Report
1 year, 10 months ago

India saved 3.4mn people through Covid-19 vaccination drive: Report

Hindustan Times  

India saved at least 3.4 million lives by undertaking a nationwide Covid-19 vaccination campaign at an unprecedented scale, said a new report released by the Union health minister, Mansukh Mandaviya, on Friday, adding that the vaccination campaign also yielded a positive economic impact by preventing a loss of $18.3 billion. India started its Covid vaccination drive on January 16, 2021, …

Nasal vaccine at govt centres in Delhi from Feb 15
1 year, 10 months ago

Nasal vaccine at govt centres in Delhi from Feb 15

Hindustan Times  

India’s first nasal vaccine for Covid-19, iNCOVACC, which was formally launched on Thursday, is likely to be made available at government centres in the national capital by mid-February, senior officials of the Delhi government said on Friday. Union health minister Mansukh Mandaviya and science and technology minister Jitendra Singh launched Bharat Biotech’s nasal Covid vaccine, iNCOVACC, on the occasion of …

India launches world’s 1st intranasal Covid vaccine: Check price, availability
1 year, 10 months ago

India launches world’s 1st intranasal Covid vaccine: Check price, availability

Hindustan Times  

The world's first made-in-India intranasal Covid-19 vaccine iNCOVACC, manufactured by Bharat Biotech, was launched on Thursday as the country marked its 74th Republic Day. Union health minister Mansukh Mandaviya launched the vaccine and emphasised India's vaccine manufacturing and innovation capability, which he said is appreciated all over the world. "As the world's first intranasal Covid-19 vaccine, this is a glorious …

'Coldspots' discovered in Covid virus, may help antibodies fight future variants: Study
1 year, 10 months ago

'Coldspots' discovered in Covid virus, may help antibodies fight future variants: Study

India TV News  

Scientists have discovered regions on the coronavirus which do not change, or 'coldspots', and that antibodies specific for these coldspots may help fight future coronaviruses, according to a new study. According to the study, sieving through over 10 million coronavirus sequences, two PhD students at the Institute for Research in Biomedicine, Switzerland and affiliated with the Università della Svizzera italiana, …

What is nasal vaccine - iNCOVACC? All you need to know
1 year, 10 months ago

What is nasal vaccine - iNCOVACC? All you need to know

India TV News  

Covid19 nasal vaccine : Union Health Minister Mansukh Mandaviya on Friday launched Bharat Biotech's first India-made nasal Vaccine, iNCOVACC, as a booster shot for Covid19. According to Bharat Biotech, the nasal vaccine is likely to prevent infection, thus, preventing the transmission of the virus. The event saw the Union Minister of State Science & Technology; Minister of State Earth Sciences; …

Centre rolls out first nasal Covid vaccine as booster
1 year, 10 months ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine
1 year, 10 months ago

Health minister Mandaviya launches Bharat Biotech's nasal Covid vaccine

Hindustan Times  

Union Health Minister Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched Bharat Biotech's nasal Covid vaccine, iNCOVACC, on the occasion of Republic Day on Thursday. The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's approval in November for restricted emergency use among adults as a heterologous booster dose. According to a statement issued …

Private hospitals with advance orders to get intranasal COVID-19 shots soon
1 year, 10 months ago

Private hospitals with advance orders to get intranasal COVID-19 shots soon

The Hindu  

Union Health Minister Mansukh Mandaviya and Minister of Science and Technology Jitendra Singh launched first-of-it’s-kind intranasal COVID-19 vaccine iNCOVACC manufactured by Hyderabad-based Vaccine developer Bharat Biotech International Limited on January 26, 2023. It is the world’s first Intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose, administered as nasal drops. The …

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched
1 year, 10 months ago

India’s first intra-nasal Covid-19 vaccine iNCOVACC launched

Live Mint  

Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh launched India's first made nasal vaccine against Covid-19 iNCOVACC. "Our nasal vaccine will be officially launched on January 26, on Republic Day," the company's chairman and managing director Krishna Ella said, participating in the 'Face-to-Face with New Frontiers in Science' segment of the IISF, organised at the …

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC
1 year, 10 months ago

COVID-19: Mansukh Mandaviya launches world's 1st Made-in-India nasal vaccine iNCOVACC

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya and Science and Technology Minister Jitendra Singh collectively launched 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday in the national capital. Who all were present: On the occasion of the launch, the Union Minister of State Science & Technology; Minister of State Earth Sciences; MoS PMO, Personnel, Public …

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today
1 year, 11 months ago

COVID-19: Health Minister Mansukh Mandaviya to launch world's 1st 'Made-in-India' nasal vaccine today

India TV News  

COVID-19 nasal vaccine launch : Union Health Minister Dr Mansukh Mandaviya will launch 'iNCOVACC', the world's first made-in-India nasal vaccine on Thursday, official sources said. According to the sources, Hyderabad-based Bharat Biotech's Intranasal heterologous booster dose is likely to be available in the market by February first week.Recently, Bharat Biotech announced iNCOVACC® as a booster dose in the country.Earlier this …

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26
1 year, 11 months ago

Bharat Biotech’s nasal vaccine likely to be launched on Jan 26

Hindustan Times  

Bhopal: Bharat Biotech’s nasal Covid-19 vaccine iNCOVACC is expected to be launched on January 26, executive chairman Krishna Ella said at an event on Saturday. “Our nasal vaccine will be officially launched on January 26 on Republic Day,” Ella told students at the Maulana Azad National Institute of Technology in Bhopal, where the India International Science Festival, 2022, is being …

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26
1 year, 11 months ago

First Indian intranasal Covid vaccine by Bharat Biotech to be launched on Jan 26

India TV News  

Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella said here on Saturday. In December, Bharat Biotech had announced that it would sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 …

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report
1 year, 11 months ago

Multiple COVID vaccine side-effects: Health Ministry clears air on recent report

Live Mint  

The Union Health Ministry has reiterated that only a small percentage of patients who receive the COVID-19 vaccine may develop serious adverse events depending on certain predisposing circumstances, refuting the reports of various side effects of the vaccine. According to a recent media report, the Central Drugs Standard Control Organization and the Indian Council of Medical Research have acknowledged "multiple …

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey
1 year, 11 months ago

Time to Join this ‘Herd’: 39% Have Boosted Their Protection against Covid Virus, Finds Survey

News 18  

At least 39% of respondents have already taken the Covid vaccine booster dose, while 6% plan to take the injectable booster and 4% the nasal one, a LocalCircles survey has found. Amid the uptick in Covid in cases in China and other countries, the Centre gave nod for Bharat Biotech’s intranasal COVID vaccine iNCOVAAC as a booster dose. Director General …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
1 year, 11 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Raise Investment in Pharma R&D, Find Cure for Substandard Drugs: Glenmark India Biz Head
1 year, 11 months ago

Raise Investment in Pharma R&D, Find Cure for Substandard Drugs: Glenmark India Biz Head

News 18  

Learning lessons from Covid, the pharmaceutical industry is expecting policy measures to increase investments in research and development, Glenmark Pharmaceuticals India’s business head told News18.com. Alok Malik, executive vice president and business head, India formulations, told News18.com that “the industry-friendly measures will boost the on-ground execution of the government’s vision of discovering India through pharma innovation.” “As one industry, we …

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy
1 year, 11 months ago

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy

News 18  

A sample of SARS-CoV-2 virus containing the BF.7, a sub-lineage of the Omicron variant, has successfully been isolated by India to assess the efficacy of available vaccines. “Scientists are studying whether the currently available vaccines are effective in preventing infections or serious illness caused by the new sub-variant,” a source was quoted as saying. India has reported at least four …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
1 year, 11 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals
1 year, 11 months ago

Bharat Biotech’s intranasal covid vaccine priced at ₹325 for govt hospitals

Live Mint  

NEW DELHI: Bharat Biotech’s intranasal covid-19 vaccine--iNCOVACC --will be available for ₹325 per dose at government hospitals, and for ₹800 in private settings, the pharma major said on Tuesday. According to the company, iNCOVACC is the world’s first intranasal vaccine for covid-19 to have received approval for a primary two-dose schedule, and as a heterologous booster dose. Clinical trials were …

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here
1 year, 11 months ago

Price of Bharat Biotech’s nasal Covid vaccine revealed. Details here

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above according to reports will be available at ₹800+ GST+ hospital charges according to sources. The country’s first intranasal covid vaccine will be rolled out in the fourth week of January as a booster dose for those …

Nasal vaccines to roll out in private hospitals soon
2 years ago

Nasal vaccines to roll out in private hospitals soon

Hindustan Times  

A new coronavirus vaccine used as a nasal spray will only be available at private health facilities and the Co-WIN platform was set to be tweaked on Friday to allow people to immediately begin booking shots, people aware of the matter said on Friday. On Thursday, India’s technical expert committee on immunization— National Technical Advisory Group on Immunisation —recommended the …

Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know
2 years ago

Bharat Biotech’s nasal vaccine on CoWIN app today: All you need to know

Live Mint  

Bharat Biotech's intranasal Covid vaccine has been approved by the Union Health Ministry as a booster dose for those aged 18 years and above and is likely to be introduced on the Co-WIN platform Friday evening. What is the new nasal vaccine developed by Bharat Biotech? This vaccine candidate was evaluated in phase I, II and III clinical trials with …

Bharat Biotech’s nasal vaccine to be available as booster dose
2 years ago

Bharat Biotech’s nasal vaccine to be available as booster dose

The Hindu  

With the threat of COVID-19 resurfacing and India ramping up preventive health surveillance measures, Health Minister Mansukh Mandaviya said on Friday that a vaccine, which could be administered as nasal drops, would henceforth be available for public use. “We have made available a nasal vaccine, developed by Bharat Biotech, that can be used as a precaution dose. A spokesperson for …

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN
2 years ago

COVID-19: Centre approves Bharat Biotech's intranasal vaccine, to be available on CoWIN

Firstpost  

The needle-free vaccine will be available at private centres. It will be introduced on the Co-WIN platform on Friday evening New Delhi: Bharat Biotech’s intranasal COVID-19 vaccine has been approved by the Ministry of Health and Family Welfare for inclusion in the vaccination programme as a booster dose for those above 18 years of age, official sources said on Thursday. …

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use
2 years ago

World’s first intra-nasal vaccine for COVID gets CDSCO nod for restricted use

Live Mint  

World's first intra-nasal vaccine for COVID developed by India has got approval from the Central Drugs Standard Control Organisation for restricted use in emergency situations in the age group of 18 and above. A press release from the vaccine maker said iNCOVACC, a recombinant replication deficient adenovirus vectored vaccine with a pre-fusion stabilised SARS-CoV-2 spike protein, is the world's first …

More vaccine choices: The Hindu Editorial on Bharat Biotech’s intranasal COVID-19 vaccine
2 years ago

More vaccine choices: The Hindu Editorial on Bharat Biotech’s intranasal COVID-19 vaccine

The Hindu  

Nearly three months after Bharat Biotech’s intranasal COVID-19 vaccine was granted emergency use approval for primary vaccination of adults, the vaccine has now been given emergency use approval as a heterologous booster in adults over 18 years. As in the case of the intranasal vaccine for primary vaccination, the booster dose too was tested only for safety and immunogenicity, but …

Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster
2 years ago

Bharat Biotech’s nasal covid vax gets CDSCO’s nod as heterologous booster

Live Mint  

Pharma firm Bharat Biotech on Monday announced that its intranasal covid-19 vaccine iNCOVACC has received approval from the Central Drugs Standard Control Organization for people above 18 years of age as a heterologous booster dose under restricted emergency use in India. With this development, INCOVACC becomes world’s first intranasal vaccine to receive both primary series and heterologous booster approval, the …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 1 month ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health
2 years, 1 month ago

What Makes India's Covid Vaccination Programme A Global Best Practice In Public Health

News 18  

On April 14, 2020, India’s Prime Minister made an appeal to scientists and researchers to take the lead in developing a vaccine against the coronavirus. The group was tasked with formulating an implementation strategy for the Covid-19 vaccine including the selection of vaccine candidates, procurement of vaccines, prioritisation of population groups for vaccination, enabling digital infrastructure, vaccine delivery platforms as …

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity
2 years, 1 month ago

Covid vaccination improves effectiveness of treatment for cancer in nose-throat cavity

The Independent  

Cancer drugs worked better after patients had had Covid-19 jabs, scientists have discovered. Patients with nasopharyngeal cancer – in the area from the back of the nose to the upper part of the throat – who had had a coronavirus vaccine “responded significantly better” to treatment than unvaccinated patients, according to German and Chinese experts. They were surprised when the …

CORBEVAX offers better immunity as a heterologous booster shot
2 years, 2 months ago

CORBEVAX offers better immunity as a heterologous booster shot

Deccan Chronicle  

HYDERABAD: Heterologous booster shots have gained significance in light of the waning effect of vaccine doses, especially against different variants of the Covid-19 virus. There is an increase in the immune response to the administration of heterologous booster shots on two counts – first cellular immunity and second, neutralizing antibodies. Administering the CORBEVAX vaccine as a heterologous booster dose provides …

Routine Immunisation Suffered Due to COVID-19, it Has to Be Put Back on Track: Mandaviya
2 years, 2 months ago

Routine Immunisation Suffered Due to COVID-19, it Has to Be Put Back on Track: Mandaviya

News 18  

Union Health Minister Mansukh Mandaviya on Thursday said routine immunisation was affected due to the coronavirus pandemic and the earlier vaccination programme has to be brought back on track. Speaking at the annual general meeting of the Developing Countries Vaccine Manufacturers Network here, Mandaviya said India achieved the feat of administering 100 crore coronavirus vaccine doses in nine months and …

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial
2 years, 2 months ago

High Hopes for Nasal Covid Vaccines Despite 'Disappointing' AstraZeneca Trial

News 18  

Nasal vaccines could still be a powerful future weapon in the fight against Covid-19 despite “disappointing” recent trial results for an AstraZeneca spray, experts say. Eric Tartour, an immunologist at the European Hospital Georges Pompidou in Paris, said that while the AstraZeneca results “are indeed disappointing”, he did not think the news “dampens hope for nasal vaccines”. However, the vaccine …

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget
2 years, 2 months ago

Health Ministry not to procure fresh COVID-19 vaccines; surrenders ₹4,237 crore from vaccination budget

The Hindu  

The government’s COVID-19 vaccination programme is in its final leg with the Health Ministry deciding against procuring more vaccines as of now and surrendering ₹4,237 crore, or nearly 85% of the 2022-23 budget allocation for inoculation purposes, to the Finance Ministry. Official sources told PTI that more than 1.8 crore doses are still available with the governments at the Centre …

How the COVID-19 pandemic altered the vaccine story in India
2 years, 2 months ago

How the COVID-19 pandemic altered the vaccine story in India

The Hindu  

Last week, Twitter temporarily blocked a post by Florida’s surgeon general Joseph A. Ladapo. Such DNA vaccines, older in provenance than mRNA vaccines, involve inserting DNA for an antigen — or the part of the virus that stimulates the immune system — into a special kind of circular DNA called plasmids that are usually only found in bacteria. In the …

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial
2 years, 2 months ago

AstraZeneca Nasal Spray Vaccine for Covid-19 Suffers Setback in Early Trial

News 18  

In a major setback, AstraZeneca and the University of Oxford’s joint trial for the nasal-spray version of the Nonreplicating viral vector vaccine against Covid-19 did not yield desired protection, reported Reuters on Tuesday. The University of Oxford said, “An antibody response in the respiratory mucous membranes was seen in only a minority of participants in the trial, which was in …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 3 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

What is a COVID-19 nasal vaccine?
2 years, 3 months ago

What is a COVID-19 nasal vaccine?

The Hindu  

Since the launch of its COVID-19 vaccine programme in early 2021, India has protected millions at home and abroad from the virus. The Hyderabad-based Bharat Biotech, the makers of Covaxin, has got an approval for its nasal vaccine from the Central Drugs Standard Control Organisation. It is for primary immunisation against COVID-19 in the 18-plus age group, for restricted use …

Explained | How does a COVID-19 nasal vaccine work?
2 years, 3 months ago

Explained | How does a COVID-19 nasal vaccine work?

The Hindu  

The story so far: On September 6, Union Health Minister Mansukh Mandaviya tweeted that the Central Drugs Standard Control Organisation had approved Bharat Biotech’s nasal vaccine for primary immunisation against COVID-19 in the 18-plus age group for restricted use in an emergency situation. A nasal vaccine is delivered through the nose or mouth and it is expected to work on …

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval
2 years, 3 months ago

Bharat Biotech’s intra-nasal COVID vaccine gets emergency use approval

The Hindu  

Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine has been approved by Central Drugs Standard Control Organisation for primary immunization against COVID-19 in 18+ age group for restricted use in emergencies, Health Minister Mansukh Mandaviya tweeted on Tuesday. Dr. Krishna Ella, chairman and managing director, Bharat Biotech, said: “iNCOVACC will be a global game changer in intra-nasal vaccines technology and delivery …

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light
2 years, 3 months ago

‘Big boost’: Bharat Biotech’s nasal Covid-19 vaccine gets green light

Hindustan Times  

Bharat Biotech's Covid-19 nasal vaccine was cleared for use in adults on Tuesday. The BBV154 intranasal vaccine received emergency use authorisation from the Drugs Controller General of India after it was proven to be safe, well-tolerated, and immunogenic in subjects in controlled clinical trials. BBV154 is believed to produce local antibodies in the upper respiratory tract which may provide the …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 3 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval
2 years, 3 months ago

Covid-19: India's first intranasal vaccine by Bharat Biotech gets DCGI approval

India TV News  

The Bharat Biotech on Tuesday got emergency use authorisation from the Drugs Controller General of India for the Intranasal Covid-19 vaccine. Union Minister of Health and Family Welfare Mansukh Mandaviya termed it a 'Big boost' to India's fight against Covid-19. Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for …

Discover Related